seekingalpha.com
/1 month ago
Latest updates for Glncy
Fresh curated links around GLNCY are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Glencore said to have set aside $480M provision for Radiant World exposure
- NEXGEL, Inc. (NXGL) Discusses Strategic Platform Reorganization and Refocus on Medical Device and Biomedical Innovation
- GLP-1s: Still Early In The Growth Story
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
seekingalpha.com
/4 weeks ago
NEXGEL, Inc. (NXGL) Discusses Strategic Platform Reorganization and Refocus on Medical Device and Biomedical Innovation...
seekingalpha.com
/1 day ago
Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Q3 2026 Earnings Call Transcript
seekingalpha.com
/1 month ago
GXO Logistics, Inc. (GXO) Presents at Morgan Stanley's 14th Annual Laguna Conference Transcript
seekingalpha.com
/1 month ago
GSK plc (GSK) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 3rd Annual Healthcare Forum Transcript
seekingalpha.com
/1 month ago
Gloo Holdings, Inc. 2026 Q2 - Results - Earnings Call Presentation
seekingalpha.com
/1 month ago
GSK plc (GSK) Presents at Bernstein's 23rd Annual Pan-European Strategic Decisions Conference Transcript
seekingalpha.com
/1 month ago
The LGL Group, Inc. (LGL) Presents at Moody Capital Disruptive Growth & Life Science Conference - Slideshow
seekingalpha.com
/1 month ago
Gladstone Investment (GAIN) Analyst/Investor Day - Slideshow
cafepharma.com
/1 month ago
Blenrep
Blenrep Anonymous (not verified) Tue, 09/08/2026 - 15:50 field_thread_url https://cafepharma.com/boards/threads/blenrep.714532/ board na...
fool.com
/1 day ago
Amgen vs. Eli Lilly: Does the GLP-1 Mania Make LLY Stock a Better Buy in 2026?
Amgen trades at half the valuation multiple of Eli Lilly while generating stronger free cash flow, but explosive growth in obesity drugs tells a different story.
seekingalpha.com
/1 month ago
NTG Clarity Networks Inc. (NCI:CA) Q2 2026 Earnings Call Transcript
seekingalpha.com
/1 month ago
Gabelli Global Utility & Income Trust Q2 2026 Commentary
qchron.com
/1 month ago
GNS Deadline: GNS Investors with Losses in Excess of $100K Have Opportunity to Lead Genius Group Limited Securities Frau...
NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers or sellers of securities of Genius Group Limited (NYSE American: GNS)...
pharmexec.com
/2 days ago
<
seekingalpha.com
/1 month ago
LGL Group: A Speculative Bet On Operational Improvement And Capital Deployment
seekingalpha.com
/1 month ago
Allient Inc. (ALNT) Presents at Lake Street 10th Annual Best Ideas Growth Conference - Slideshow
seekingalpha.com
/2 weeks ago
GNT And GNT.PR.A: Balancing Yield, Security, And Interest Rate Risk
fool.com
/1 month ago
Novo Nordisk May Be Poised to Outpace Eli Lilly With This Key Catalyst
Demand for Novo Nordisk's new GLP-1 pill is rising quickly, while Eli Lilly's new pill faces an important headwind.
seekingalpha.com
/3 weeks ago
Gloo's Revenue Nearly Tripled In Q2, But I'm Still Selling
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Glncy
seekingalpha.com
Recent coverage from public sources
Public source
cafepharma.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
fool.com
Recent coverage from public sources
Public source
pharmexec.com
Recent coverage from public sources
Public source